argenx Sets July 23 for Half-Year Results Call

argenx will report half-year 2026 financial results and issue a second-quarter business update on July 23 before the market opens. The immunology company will host a conference call and webcast at 2:30 p.m. CET, or 8:30 a.m. ET.

Management is expected to discuss Vyvgart's commercial trajectory, the pipeline beyond the FcRn blocker, and progress in earlier-stage programs. The call follows the company's first-quarter update in May, when argenx reiterated full-year guidance.

Investors can dial in 15 minutes ahead using the access code 3810049. A replay of the webcast will remain on argenx's investor site for about a year.